The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed to those with Type 2 diabetes, it is also used for weight loss.

The study suggested that GLP1-RA-treated patients had a 30% lower risk of dementia compared to those taking other anti-diabetes drugs called sulfonylureas, and a 23% lower risk compared to those ...

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher.